Aging Breast Spatial Atlas: Linking Tissue Changes to Cancer Risk

A new single-cell spatial atlas of the aging breast reveals how normal tissue changes over time may influence breast cancer risk, offering researchers a detailed map of cellular and molecular shifts that occur in healthy breast tissue as women age.

The study, published in Nature Cancer and led by researchers at the Wellcome Sanger Institute and the University of Cambridge, analyzed nearly 800,000 individual cells from breast tissue donated by 48 women ranging in age from 16 to 91. By combining single-cell RNA sequencing with spatial transcriptomics, the team created a high-resolution map showing how different cell types are distributed and how their gene expression changes across the lifespan.

One of the key findings is that the composition of the breast stroma — the supportive connective tissue — shifts significantly with age. There is a gradual increase in fibroblast subtypes associated with tissue remodeling and inflammation, alongside a decline in certain adipocyte precursors. These changes occur in the intralobular stroma, the region surrounding milk ducts and lobules where most breast cancers originate.

“We observed that aging breast tissue doesn’t just accumulate random damage; it undergoes structured, predictable changes in both cellular composition and spatial organization,” said Dr. Fidelis Tan, a postdoctoral researcher at the Wellcome Sanger Institute and co-first author of the study. “These alterations create a microenvironment that may either support or resist the early steps of carcinogenesis, depending on the context.”

The researchers also identified age-related changes in immune cell populations within the breast. Older tissue showed increased presence of macrophages with inflammatory phenotypes and altered T-cell distributions, suggesting a shift toward chronic low-grade inflammation — a known factor in cancer development. At the same time, certain regulatory T-cell populations decreased, potentially reducing immune surveillance in the tissue.

Importantly, the study found that some of these age-related stromal and immune changes resemble those seen in breast cancer tissue, particularly in estrogen receptor-positive tumors. This raises the possibility that the normal aging process may prime the breast tissue for tumorigenesis by creating conditions that favor the growth of pre-malignant cells.

“It’s not that aging directly causes cancer, but rather that the tissue becomes more permissive to abnormal growth over time,” explained Dr. Sarah Teichmann, senior author and head of Cellular Genetics at the Wellcome Sanger Institute. “Think of it like soil quality changing over years — even if you plant the same seed, the likelihood of it taking hold and thriving depends on the condition of the ground.”

The atlas also highlighted regional differences within the breast. Changes in the lobular regions — where milk is produced — were more pronounced than in the ductal systems, which may help explain why lobular carcinomas, though less common, often present diagnostic challenges and tend to arise in older women.

To ensure the findings were not influenced by hormonal fluctuations or reproductive history, the researchers stratified their analysis by menopausal status, parity and hormone replacement therapy use. While menopause was associated with accelerated stromal changes, many of the core aging patterns persisted even after adjusting for these factors, suggesting intrinsic aging processes play a major role.

The data from this study have been made publicly available through the Human Cell Atlas initiative, allowing researchers worldwide to explore the molecular signatures of aging breast tissue and compare them with cancer datasets. The team hopes this resource will improve early detection strategies and inform prevention efforts, particularly for women at higher risk due to age or family history.

Experts not involved in the study noted that while the atlas provides an unprecedented view of healthy breast aging, further research is needed to determine how these changes interact with genetic risks, such as BRCA mutations, or lifestyle factors like obesity and alcohol consumption.

“What we have is a foundational resource,” said Dr. Ana Soto, professor of integrative biology at Tufts University School of Medicine, who studies tissue organization and cancer. “Now we can ask: if we know what normal aging looks like at the single-cell level, can we detect deviations earlier — before a tumor forms?”

The researchers plan to extend the atlas to include tissue from women with known precancerous lesions and those undergoing risk-reducing surgeries, aiming to pinpoint the exact transitions from normal aging to early malignancy. Long-term, such maps could guide interventions designed to maintain a youthful, resistant tissue microenvironment.

For now, the study reinforces the importance of considering tissue aging not just as a passive backdrop to cancer, but as an active participant in shaping risk. As breast cancer remains the most commonly diagnosed cancer in women worldwide, understanding how the healthy breast evolves over time may open new pathways for prevention — especially in the growing population of postmenopausal women.